The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,023,802 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Southcentral Foundation, an Alaska Native non-profit healthcare organization. The 5-year grant aims to reduce unmet treatment needs and opioid overdose-related deaths in the Matanuska-Susitna Borough and northern Anchorage, Alaska through the provision of culturally...
The Kenaitze Indian Tribe was awarded a $998,524 project grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The 5-year grant, which runs from September 30, 2024 to September 29, 2029, will enhance the availability of medication-assisted treatment (MAT) case management services to support at least 75 Alaska Native/American Indian clients...
The Chickaloon Native Village was awarded a $386,902 Project Grant by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant funding will support the Chickaloon Native Village Tribal Opioid Response (TOR) Program, which provides comprehensive substance use disorder (SUD) recovery services to any community member in the Chickaloon Alaska Native...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $750,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Kawerak, Inc., a non-profit tribal consortium in Nome, Alaska. The grant funding will support the Bering Strait Opioid Response Initiative, a comprehensive project aimed at transforming substance use prevention, harm reduction, treatment, and recovery services for Alaska...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,000,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Village of Alakanuk in Alaska. The grant will fund the Alakanuk Tribal Opioid Response Program over a 5-year period from September 2024 to September 2029. The program will implement culturally informed community and school-based opioid prevention education...
The Akiachak Native Community was awarded a $1,250,000 Project Grant by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. This 5-year grant will fund culturally informed and responsive community and school-based opioid prevention education activities to raise awareness about the dangers of opioid use. The program will teach community members and youth to...
The Ketchikan Indian Community (KIC) was awarded a $732,213 Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant aims to enhance opioid use disorder (OUD) prevention and treatment services for adults in the Ketchikan community, including those facing homelessness and socioeconomic challenges. Key objectives are to: 1) Expand OUD...
The Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,005,154 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Southeast Alaska Regional Health Consortium (SEARHC). This 5-year grant (9/30/2024 - 9/29/2029) will enable SEARHC to expand evidence-based opioid use disorder treatment services at its clinics in Juneau, Alaska and...
The Native Village of Goodnews Bay received a $999,996 project grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant will fund the establishment of a local counseling program to address the opioid crisis in the Goodnews Bay community and surrounding region. Key objectives include providing prevention services in schools,...
This Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) provides $500,000.00 in funding to the Maniilaq Association to serve the predominantly Alaska Native population of the Northwest Arctic region of Alaska. The primary goals of this 5-year project are to: (1) develop a culturally informed and responsive, evidence-based community...
The Ninilchik Village, a federally recognized tribal government, received a $341,268 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program. The grant funding, awarded on September 30, 2024, aims to improve the Ninilchik Traditional Council's (NTC) addiction clinic and ensure that medication-assisted treatment (MAT) is available to all community members using opioids, regardless of race. Key objectives include utilizing a mobile clinic van to increase access, integrating case managers into primary care, leveraging peer support, providing substance use outreach and education, and enhancing screening and care coordination for people with opioid use disorder at risk of hepatitis C. These enhancements are expected to increase community access to MAT, encourage sustained abstinence from opioids, and reduce the risks of relapse, overdose, infectious disease, diversion, and recidivism. The grant will serve a diverse population, including low-income individuals, Alaska Natives, and those with stimulant use disorder and co-occurring mental health conditions.